Literature DB >> 11408359

Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.

D L Lanza1, G S Yost.   

Abstract

3-Methylindole (3 MI) is a selective pulmonary toxicant, and cytochrome P450 (P450) bioactivation of 3 MI, through hydroxylation, epoxidation, or dehydrogenation pathways, is a prerequisite for toxicity. CYP2F1 and CYP2F3 exclusively catalyze the dehydrogenation of 3 MI to 3-methyleneindolenine, without detectable formation of the hydroxylation or epoxidation products. It was not known whether 3 MI is simply an excellent dehydrogenation substrate for all P450 enzymes, or whether certain cytochrome P450s responsible for 3 MI bioactivation have unique active sites that only catalyze the dehydrogenation of the molecule, while other P450s would catalyze only the oxygenation of 3 MI. Therefore, the kinetics of product formation by the CYP2F1 and CYP2F3 enzymes were compared with other cytochrome P450 enzymes. The enzymes tested were CYP1A1, CYP1A2, CYP1B1, and CYP2E1. The CYP1A1 and CYP1A2 enzymes produced all three 3 MI metabolites: the dehydrogenation product, 3-methyleneindolenine (V(max)/K(m) = 4 and 22, respectively); the hydroxylation product, indole-3-carbinol (V(max)/K(m) = 42 and 100, respectively); and the epoxidation product, 3-methyloxindole (V(max)/K(m) = 4 and 72, respectively). These CYP1A enzymes catalyzed oxygenation of 3 MI at much faster rates than dehydrogenation. CYP1B1 produced indole-3-carbinol (V(max)/K(m) = 85) and 3-methyloxindole (V(max)/K(m) = 7), and CYP2E1 only produced 3-methyloxindole (V(max)/K(m) = 98), but neither enzyme catalyzed the formation of the dehydrogenated product. Six additional P450 enzymes that were tested formed none of the dehydrogenation product. The ability of the various CYP1 family enzymes to catalyze the formation of all three major 3 MI metabolites, along with the specific oxygenation by CYP2E1, illustrates that dehydrogenation of 3 MI is not a substrate-directed process, but that the members of the CYP2F family possess unique active sites that specifically catalyze only the dehydrogenation mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408359

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  19 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.

Authors:  Thomas A Baillie; Allan E Rettie
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

Review 3.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

4.  Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor.

Authors:  Martina Stepankova; Iveta Bartonkova; Eva Jiskrova; Radim Vrzal; Sridhar Mani; Sandhya Kortagere; Zdenek Dvorak
Journal:  Mol Pharmacol       Date:  2018-04-06       Impact factor: 4.436

5.  Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells.

Authors:  Barbora Vyhlídalová; Karolína Poulíková; Iveta Bartoňková; Kristýna Krasulová; Jan Vančo; Zdeněk Trávníček; Sridhar Mani; Zdeněk Dvořák
Journal:  Toxicol Lett       Date:  2019-06-12       Impact factor: 4.372

6.  3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively.

Authors:  Jessica M Weems; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

7.  The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.

Authors:  Jaime D'Agostino; Xiaoliang Zhuo; Mohammad Shadid; Daniel G Morgan; Xiuling Zhang; W Griffith Humphreys; Yue-Zhong Shu; Garold S Yost; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2009-07-16       Impact factor: 3.922

8.  Directed evolution reveals requisite sequence elements in the functional expression of P450 2F1 in Escherichia coli.

Authors:  James B Y H Behrendorff; Chad D Moore; Keon-Hee Kim; Dae-Hwan Kim; Christopher A Smith; Wayne A Johnston; Chul-Ho Yun; Garold S Yost; Elizabeth M J Gillam
Journal:  Chem Res Toxicol       Date:  2012-08-29       Impact factor: 3.739

9.  3-Methylindole is mutagenic and a possible pulmonary carcinogen.

Authors:  Jessica M Weems; Ned S Cutler; Chad Moore; William K Nichols; David Martin; Evan Makin; John G Lamb; Garold S Yost
Journal:  Toxicol Sci       Date:  2009-08-21       Impact factor: 4.849

10.  Single mutations change CYP2F3 from a dehydrogenase of 3-methylindole to an oxygenase.

Authors:  Jaya S Kartha; Konstantine W Skordos; Hao Sun; Clifton Hall; LaHoma M Easterwood; Christopher A Reilly; Eric F Johnson; Garold S Yost
Journal:  Biochemistry       Date:  2008-08-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.